Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observational study of dapoxetine hydrochloride use frequency in premature ejaculation
ChiCTR-OCH-14005091Phase 4Recruiting
- Sponsor
- Huashan Hospital
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dapoxetine in premature ejaculation (PE) (5 arms), sponsored by Huashan Hospital. Primary endpoints: Intravaginal ejaculatory latency time, Premature Ejaculation Profile and 2 more. Started Sep 2014; status: recruiting.
02
Drugs
dapoxetine
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on ChiCTR-OCH-14005091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCH-14005091.